Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 854-857

  Sporer, Bernd ^a   Paul, Robert ^b   Koedel, Uwe ^b   Grimm, Roland ^b   Wick, Manfred ^b   Goebel, Frank D ^b   Pfister, Hans W ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GELATINASE B; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID CYTOLOGY; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0031656032     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515342     Document Type: Article

References (15)

1. Price RW. Neurological complications of HIV infection. Lancet 1996; 348:445-52.
2. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988;45:954-8.
3. Singer EJ, Syndulko K, Fahy-Chandon B, Schmid P, Conrad A, Tourtellotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994; 7:265-71.
4. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome; immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32:658-66.
5. Rosenberg GA, Kornfeld M, Estrada EY, Kelley RO, Liotta LA, Stetler-Stevenson WG. TIMP-2 reduces proteolytic opening of the blood-brain barrier type IV collagenase. Brain Res 1992;576:203-7.
6. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 1995;376:345-55.
7. Rosenberg GA, Dencoff JE, Correa N Jr, Reiners M, Ford CC. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 1996;46:1626-32.
8. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Immunol 1989;23:109-16.
9. Wiley CA, Achim CL, Schrier RD, Heyes MP, McCutchan JA, Grant I. Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis. AIDS 1992;6:1299-307.
10. Dhawan S, Weeks BS, Soderland C, et al. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol 1995;154:422-32.
11. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol 1996; 157:974-7.
12. Xia M, Leppert D, Hauser SL, et al. Stimulus specificity of matrix metalloproteinases dependence of human T cell migration through a model basement membrane. J Immunol 1996; 156:160-7.
13. Stüve O, Dooley NP, Uhm JH et al. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996;40:853-63.
14. Gottschall PE, Deb S. Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmunomodulation 1996; 3:69-75.
15. Buettner A, Mehraein P, Weis S. Vascular changes in the cerebral cortex in HIV-1 infection. An immunohistochemical and lectinhistochemical investigation. Acta Neuropathol 1996;92:35-41.